Unknown

Dataset Information

0

Accelerating the in vitro emulation of Alzheimer's disease-associated phenotypes using a novel 3D blood-brain barrier neurosphere co-culture model.


ABSTRACT: High failure rates in clinical trials for neurodegenerative disorders such as Alzheimer's disease have been linked to an insufficient predictive validity of current animal-based disease models. This has created an increasing demand for alternative, human-based models capable of emulating key pathological phenotypes in vitro. Here, a three-dimensional Alzheimer's disease model was developed using a compartmentalized microfluidic device that combines a self-assembled microvascular network of the human blood-brain barrier with neurospheres derived from Alzheimer's disease-specific neural progenitor cells. To shorten microfluidic co-culture times, neurospheres were pre-differentiated for 21 days to express Alzheimer's disease-specific pathological phenotypes prior to the introduction into the microfluidic device. In agreement with post-mortem studies and Alzheimer's disease in vivo models, after 7 days of co-culture with pre-differentiated Alzheimer's disease-specific neurospheres, the three-dimensional blood-brain barrier network exhibited significant changes in barrier permeability and morphology. Furthermore, vascular networks in co-culture with Alzheimer's disease-specific microtissues displayed localized β-amyloid deposition. Thus, by interconnecting a microvascular network of the blood-brain barrier with pre-differentiated neurospheres the presented model holds immense potential for replicating key neurovascular phenotypes of neurodegenerative disorders in vitro.

SUBMITTER: Ko EC 

PROVIDER: S-EPMC10600382 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature

altmetric image

Publications

Accelerating the in vitro emulation of Alzheimer's disease-associated phenotypes using a novel 3D blood-brain barrier neurosphere co-culture model.

Ko Eunkyung Clare EC   Spitz Sarah S   Pramotton Francesca Michela FM   Barr Olivia M OM   Xu Ciana C   Pavlou Georgios G   Zhang Shun S   Tsai Alice A   Maaser-Hecker Anna A   Jorfi Mehdi M   Choi Se Hoon SH   Tanzi Rudolph E RE   Kamm Roger D RD  

Frontiers in bioengineering and biotechnology 20231009


High failure rates in clinical trials for neurodegenerative disorders such as Alzheimer's disease have been linked to an insufficient predictive validity of current animal-based disease models. This has created an increasing demand for alternative, human-based models capable of emulating key pathological phenotypes <i>in vitro</i>. Here, a three-dimensional Alzheimer's disease model was developed using a compartmentalized microfluidic device that combines a self-assembled microvascular network o  ...[more]

Similar Datasets

| S-EPMC6794630 | biostudies-literature
| S-EPMC5853739 | biostudies-literature
| S-EPMC6372635 | biostudies-literature
| S-EPMC7359311 | biostudies-literature
| S-EPMC9463449 | biostudies-literature
| S-EPMC5876397 | biostudies-literature
| S-EPMC6181937 | biostudies-literature
| S-EPMC4122330 | biostudies-literature
| S-EPMC5670242 | biostudies-literature
| S-EPMC6819412 | biostudies-literature